Individuals carrying APOE4 showed significantly more CICI in treatments of breast cancer (Ahles et al., 2003; Mandelblatt et al., 2018) and testicular cancer (Amidi et al., 2017) than those lacking APOE4. Here, APOE is linked to testicular cancer.